Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Other financing activities (2020 - 2025)

InMed Pharmaceuticals has reported Other financing activities over the past 5 years, most recently at $137178.0 for Q3 2025.

  • For Q3 2025, Other financing activities fell 28.49% year-over-year to $137178.0; the TTM value through Dec 2025 reached $386634.0, up 40.77%, while the annual FY2025 figure was $883978.0, 57.25% up from the prior year.
  • Other financing activities for Q3 2025 was $137178.0 at InMed Pharmaceuticals, up from $57632.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $1.1 million in Q4 2022 and troughed at $25191.0 in Q3 2023.
  • A 5-year average of $351639.8 and a median of $158148.0 in 2021 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: tumbled 89.54% in 2022 and later soared 661.48% in 2024.
  • Year by year, Other financing activities stood at $179118.0 in 2021, then skyrocketed by 536.02% to $1.1 million in 2022, then tumbled by 97.79% to $25191.0 in 2023, then surged by 128.78% to $57632.0 in 2024, then skyrocketed by 138.02% to $137178.0 in 2025.
  • Business Quant data shows Other financing activities for INM at $137178.0 in Q3 2025, $57632.0 in Q4 2024, and $191824.0 in Q3 2024.